Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03770702

Statins and ARBs on Rheumatoid Activity

Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Rheumatoid Arthritis Arthritis Arthritis, Rheumatoid Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Sherief Abd-Elsalam

Tanta, 35111, Egypt

Location status: Recruiting

Location contact

Ahmed El-Abd, Msc

CONTACT

About this study

The study aims at ivestigating and comparing the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Rheumatoid arthritis.

Exclusion criteria

  • Pregnant or lactating
  • Hepatic or renal impairment.

Treatment and study plan

Angiotensin Receptor Blockers

Drug

Candesartan

Other names: Cansartan

Statins

Drug

Atorvastatin

Other names: Ator

Primary outcomes

  1. Change in disease activity score

    Time frame: 6 months

    DAS28-ESR

Study contacts

Contact information is provided by the study sponsor or research team.

Sherief Abd-Elsalam, Ph D

CONTACT

[email protected]

00201147773440

Sponsors and collaborators

Lead sponsor

Sherief Abd-Elsalam

Other

Registry information

Official study title

Investigational and Comparative Study Between the Anti-inflammatory Effectof Both Angiotensin Reeptor Blockers and Statins on Rheumatoid Arthritis Disease Activity on Egyptian Patients

Important dates

Study start
2018
Primary completion
2025
Study completion
2026
First posted
Dec 10, 2018
Registry last updated
Dec 10, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.